Middle East and Africa Respiratory Monitoring Devices Market Report

Middle East and Africa Respiratory Monitoring Devices Market Size

The MEA Respiratory Monitoring Devices market size was valued at USD 1.36 billion in 2025. The size of the MEA Respiratory Monitoring Devices market is estimated to reach USD 2.31 billion by 2034 from a market value of USD 1.44 billion in 2026, at a CAGR of 6.07%.

The Middle East and Africa (MEA) respiratory monitoring devices market covers a wide range of diagnostic and therapeutic tools designed to assess, track, and manage respiratory functions in patients suffering from chronic or acute pulmonary disorders. These devices include spirometers, capnographs, peak flow meters, pulse oximeters, and sleep apnea monitors, among others. They are deployed across hospitals, clinics, ambulatory care centers, and home healthcare settings to facilitate early detection, continuous monitoring, and effective management of conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep-disordered breathing.

In recent years, the region has witnessed a growing burden of respiratory diseases, particularly in countries like Saudi Arabia, Egypt, and South Africa.

MARKET DRIVERS

Rising Prevalence of Chronic Respiratory Diseases

One of the key drivers of the MEA respiratory monitoring devices market is the increasing prevalence of chronic respiratory diseases, especially chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea.

According to the Global Burden of Disease Study conducted by the Institute for Health Metrics and Evaluation (IHME), COPD was ranked as the third leading cause of death globally in 2021, with the Middle East experiencing a significant share of this burden. In Saudi Arabia alone, over 2.3 million people were estimated to suffer from COPD in 2022, driven largely by high tobacco use and exposure to desert dust and industrial pollutants.

Similarly, asthma remains a major public health concern across the region. This trend has led to increased hospital admissions and outpatient visits, necessitating the widespread adoption of respiratory monitoring devices for accurate diagnosis and long-term disease management.

Moreover, the growing geriatric population in several MEA countries, particularly in North Africa and the Gulf, has further amplified the need for these devices. Older adults are more susceptible to respiratory decline, requiring regular monitoring. Governments in the region have begun investing in pulmonary rehabilitation programs and home-based respiratory care, which in turn is driving the demand for portable and wearable monitoring technologies.

Expansion of Healthcare Infrastructure and Government Initiatives

Another major driver of the MEA respiratory monitoring devices market is the expansion of healthcare infrastructure and increased government spending on public health systems. Countries such as Saudi Arabia, the UAE, and South Africa have been actively modernizing their healthcare facilities, incorporating advanced diagnostics and telehealth services to improve patient outcomes. According to the World Bank, healthcare expenditure in the GCC region rose by nearly 6% annually between 2018 and 2022, with Saudi Arabia allocating over USD 30 billion to healthcare in 2023 alone.

Governments in the region are also launching targeted initiatives aimed at managing non-communicable diseases, including respiratory conditions. For instance, the UAE’s National Strategy for Public Health 2021–2025 includes specific measures to combat COPD and asthma through early screening and better access to monitoring tools. Similarly, Egypt’s Ministry of Health launched a national program in 2022 to equip primary healthcare centers with essential diagnostic equipment, including spirometers and oximeters.

Besides, the rise in private sector participation in healthcare delivery has resulted in improved access to high-quality medical devices. Private hospitals and clinics in countries like Kenya and Nigeria are increasingly adopting digital health platforms that integrate remote respiratory monitoring systems. This shift toward technologically enabled healthcare delivery is significantly boosting the uptake of respiratory monitoring devices across the MEA region.

MARKET RESTRAINTS

Limited Access to Advanced Medical Devices in Rural and Low-Income Areas

Despite the growing demand for respiratory monitoring devices, a major restraint in the MEA region is the limited access to advanced diagnostic tools in rural and low-income areas. Many countries in Sub-Saharan Africa and parts of the Middle East continue to face challenges related to inadequate healthcare infrastructure, poor distribution networks, and insufficient funding for medical device procurement.

According to the World Health Organization (WHO), less than 40% of healthcare facilities in low-income African countries have reliable access to essential medical equipment, including basic respiratory diagnostic tools.

In countries such as Ethiopia, Somalia, and Sudan, where a majority of the population resides in rural areas, access to even basic healthcare services remains a challenge. This gap in accessibility hampers early diagnosis and timely intervention, limiting the overall market growth.

Furthermore, the lack of trained healthcare professionals to operate and interpret data from advanced respiratory monitoring systems adds another layer of complexity. As per the World Bank, physician density in Sub-Saharan Africa averages just 0.2 doctors per 1,000 people, compared to over 3.5 in the Gulf Cooperation Council (GCC) countries.

High Cost of Advanced Respiratory Monitoring Equipment

The high cost of advanced respiratory monitoring devices poses a significant barrier to market growth in the MEA region. While technologically sophisticated devices such as digital spirometers, capnographs, and integrated sleep monitoring systems offer enhanced diagnostic accuracy, they often come with prohibitive price tags that limit their adoption, especially in public healthcare institutions and small private clinics.

Apart from these, ongoing maintenance, calibration, and software licensing fees further add to the financial burden. A 2022 study published by the African Journal of Respiratory Medicine found that nearly 60% of respiratory diagnostic devices in public hospitals across West Africa were either non-functional or underutilized due to a lack of maintenance funds. This situation discourages investment in new equipment and limits the scalability of respiratory monitoring capabilities across the MEA region.

MARKET OPPORTUNITIES

Growth of Telemedicine and Remote Patient Monitoring Solutions

One of the most promising opportunities in the MEA respiratory monitoring devices market is the rapid expansion of telemedicine and remote patient monitoring (RPM) solutions. With increasing internet penetration, smartphone usage, and mobile network coverage across the region, healthcare providers are increasingly adopting digital platforms to deliver care beyond traditional clinical settings.

In countries such as South Africa, Egypt, and the UAE, telehealth initiatives have gained momentum post-pandemic. According to the International Telecommunication Union (ITU), mobile cellular subscriptions in Africa reached over 500 million in 2023, enabling broader access to connected health technologies. This digital transformation has paved the way for the integration of portable respiratory monitoring devices with cloud-based analytics and AI-driven diagnostics.

For example, companies like ResMed and Philips have introduced smart respiratory monitoring systems that allow real-time tracking of patients’ lung function and oxygen saturation levels from home environments. These systems not only enhance patient compliance but also reduce hospital readmissions and emergency visits.

MARKET OPPORTUNITIES

Increasing Adoption of Portable and Wearable Respiratory Monitoring Devices

The rising preference for portable and wearable respiratory monitoring devices presents a significant growth opportunity in the MEA market. These compact, user-friendly devices enable continuous monitoring outside clinical environments, supporting early detection and personalized treatment of respiratory conditions.

In particular, the adoption of wearable oximeters and smart inhalers has seen an uptick in countries such as Kuwait, Qatar, and South Africa, where chronic respiratory conditions are prevalent.

Technological advancements have made these devices more affordable and accessible. Additionally, startups in the region are introducing innovative wearables tailored to local needs, such as dust-exposure monitoring for construction workers in arid regions.

With rising awareness of preventive healthcare and growing consumer interest in personal wellness tracking, the demand for wearable respiratory monitoring solutions is anticipated to expand rapidly across the MEA region, creating lucrative opportunities for device manufacturers and service providers alike.

MARKET CHALLENGES

Regulatory Complexity and Lack of Standardization

One of the foremost challenges facing the MEA respiratory monitoring devices market is the regulatory complexity and lack of standardized approval processes across different countries in the region. Unlike mature markets such as the U.S. or Europe, the MEA region comprises diverse regulatory frameworks with varying requirements for device registration, clinical trials, and post-market surveillance.

For example, while the Gulf Cooperation Council (GCC) has made efforts to harmonize medical device regulations through the GCC Medical Device Regulation (MDR), implementation remains inconsistent across member states. Meanwhile, countries like Egypt, Morocco, and South Africa maintain separate regulatory authorities with distinct documentation and compliance procedures.

This fragmented regulatory landscape increases time-to-market and operational costs for manufacturers, particularly smaller firms without dedicated regulatory affairs teams. It also limits the availability of cutting-edge devices in certain markets, hindering patient access to advanced care options.

Limited Awareness and Low Disease Detection Rates

Another critical challenge impeding the growth of the MEA respiratory monitoring devices market is the limited awareness about respiratory diseases and low detection rates, particularly in rural and underserved communities. Despite the rising burden of chronic respiratory conditions, public understanding of symptoms, risk factors, and available diagnostic tools remains poor.

According to the Forum of International Respiratory Societies (FIRS), more than 70% of COPD cases in Sub-Saharan Africa go undiagnosed due to a lack of awareness and insufficient screening programs. A similar trend is observed in parts of the Middle East, where cultural stigma around chronic illness and limited patient education contribute to delayed diagnosis.

In addition, there is a general underutilization of preventive healthcare services in many MEA countries. A 2023 survey by the African Health Observatory found that less than 15% of adults in countries like Nigeria and Tanzania had undergone any form of pulmonary function testing, even if they exhibited persistent respiratory symptoms.

Low disease awareness translates into reduced demand for monitoring devices, especially in community-based and primary healthcare settings. Addressing this issue requires sustained public health campaigns, training for frontline healthcare workers, and integration of respiratory screening into national health programs all of which are currently underdeveloped in much of the region.

SEGMENTAL ANALYSIS

By Diagnostic Devices

The spirometers segment held the largest market share, accounting for 42.2% of total revenue in 2024. The dominance of this segment is primarily attributed to the widespread use of spirometry in diagnosing chronic obstructive pulmonary disease (COPD), asthma, and other obstructive lung disorders across both clinical and ambulatory settings.

One key driver behind the continued growth of spirometers is the rising prevalence of COPD in the region. According to the World Health Organization (WHO), approximately 5 million people suffer from COPD in the Gulf Cooperation Council (GCC) countries alone, with high smoking rates and exposure to environmental pollutants such as desert dust contributing significantly to the disease burden. This has led to increased demand for accurate diagnostic tools, particularly in hospital-based pulmonary clinics and specialized respiratory care centers.

Also, government-led screening initiatives are playing a pivotal role in expanding spirometer adoption. In Saudi Arabia, for example, the Ministry of Health launched a national COPD awareness campaign in 2022 that included free spirometry testing in over 100 primary healthcare centers.

Moreover, advancements in digital spirometry, including portable and cloud-connected models, have improved accessibility in remote areas. Companies like Nihon Kohden and Schiller have introduced cost-effective, handheld spirometers tailored for emerging markets, further supporting the segment’s strong position in the MEA market.

The peak flow meter segment is projected to grow at the fastest CAGR of nearly 9.6% during the forecast period. This rapid expansion is driven by increasing awareness of asthma management, especially among children and young adults, and the growing emphasis on home-based monitoring solutions.

Asthma remains a significant public health concern across the MEA region, and as per the International Study of Asthma and Allergies in Childhood (ISAAC), over 20% of schoolchildren in the UAE suffer from asthma symptoms, one of the highest rates globally. Unlike COPD, which typically affects older populations, asthma predominantly impacts younger individuals who benefit from regular peak flow monitoring to track their condition and adjust medication accordingly.

Furthermore, the affordability and ease of use of peak flow meters make them ideal for deployment in low-resource environments. In rural parts of Egypt and Kenya, where access to advanced diagnostic equipment is limited, non-invasive tools like peak flow meters are being integrated into community-based asthma management programs.

In addition, manufacturers are introducing smart peak flow meters equipped with Bluetooth connectivity and mobile app integration. These innovations are gaining traction in urban centers like Tel Aviv and Cape Town, where patients prefer digitally enabled self-monitoring tools.

By Monitoring Devices

The pulse oximeters accounted for the maximum revenue share, capturing 38.1% of the market in 2024. Their widespread adoption is largely due to their critical role in measuring blood oxygen saturation levels, making them indispensable in managing conditions such as COPD, pneumonia, and sleep apnea.

One major factor driving the dominance of pulse oximeters is the surge in respiratory illnesses exacerbated by environmental factors. According to the Institute for Health Metrics and Evaluation (IHME), lower respiratory infections remain among the top five causes of mortality in Sub-Saharan Africa, necessitating continuous oxygen level monitoring in both hospital and home settings. Additionally, the aftermath of the COVID-19 pandemic has reinforced the importance of oxygen saturation tracking, leading to increased procurement of pulse oximeters by public health systems.

Another key driver is the proliferation of affordable and portable pulse oximeters in the MEA region. Similarly, in Saudi Arabia, hospitals have integrated wireless pulse oximeters into ICU monitoring systems, enhancing real-time patient surveillance.

Moreover, rising consumer interest in personal health monitoring has spurred retail sales of pulse oximeters. With growing awareness of preventive healthcare and increasing telemedicine adoption, pulse oximeters continue to maintain their stronghold in the MEA market.

The sleep test devices are expected to register the highest CAGR of around 11.2%. This accelerated growth is primarily fueled by the rising prevalence of sleep-disordered breathing, particularly obstructive sleep apnea (OSA), and the growing recognition of its impact on overall health.

In the United Arab Emirates, a 2023 study published by the Dubai Medical College revealed that nearly 35% of adults suffer from moderate to severe sleep apnea, often linked to rising obesity rates and sedentary lifestyles. This growing awareness has prompted healthcare providers to adopt portable sleep testing devices for early diagnosis and treatment planning.

Besides, the shift toward home-based diagnostics is accelerating the adoption of sleep test devices. Traditional polysomnography requires overnight hospital stays, which can be costly and inconvenient. Portable sleep apnea monitors, on the other hand, offer a more accessible alternative. For instance,

Government and private sector investments in sleep disorder management programs are also contributing to this trend. Coupled with technological advancements and increasing insurance coverage, these developments are propelling the sleep test devices segment into a high-growth trajectory within the MEA respiratory monitoring market.

REGIONAL ANALYSIS

Kingdom of Saudi Arabia (KSA) Respiratory Monitoring Devices Market Analysis

Saudi Arabia had the largest market share in the MEA respiratory monitoring devices market, accounting for 22.1% of total regional revenue in 2024. As a leader in healthcare modernization within the GCC, the country has made significant strides in upgrading its medical infrastructure, particularly in respiratory care.

One of the primary drivers behind Saudi Arabia’s dominant position is the rising incidence of chronic respiratory diseases. In response, the government has implemented nationwide screening programs and invested heavily in pulmonary rehabilitation centers.

Apart from these, Vision 2030 has catalyzed healthcare reforms, encouraging the adoption of advanced diagnostic and monitoring technologies. Furthermore, partnerships with global medical device manufacturers such as Philips and GE Healthcare have facilitated the introduction of next-generation respiratory monitoring equipment in hospitals and clinics across major cities like Riyadh and Jeddah.

United Arab Emirates (UAE) Respiratory Monitoring Devices Market Analysis

The UAE is another key player in the market. The country’s well-developed healthcare system, combined with proactive government policies, has positioned it as a key player in the adoption of advanced respiratory diagnostics and monitoring solutions.

One of the main growth drivers is the high prevalence of asthma and allergic respiratory conditions. This has led to increased utilization of spirometers, peak flow meters, and wearable oximeters in both hospital and home settings.

Moreover, the UAE government has been actively integrating digital health technologies into its healthcare delivery model. Such initiatives are not only improving patient outcomes but also creating new opportunities for device manufacturers.

Additionally, the presence of world-class medical facilities and a growing number of international healthcare investors has contributed to the rapid adoption of innovative respiratory monitoring technologies. The UAE's commitment to building a future-ready healthcare ecosystem ensures sustained growth in this segment of the market.

South Africa Respiratory Monitoring Devices Market Analysis

South Africa accounts for a notable share of the MEA respiratory monitoring devices market. It serves as a healthcare hub for Sub-Saharan Africa, with a relatively developed medical infrastructure compared to its regional counterparts, enabling higher penetration of respiratory monitoring technologies.

One of the key factors influencing market growth is the high burden of infectious respiratory diseases. According to the South African Medical Research Council, lower respiratory tract infections remain among the top three causes of death in the country, particularly affecting children under five and immunocompromised individuals. This has led to increased demand for pulse oximeters and gas analyzers in both public and private hospitals.

Another important driver is the expansion of medical aid schemes and government-funded healthcare programs.

Moreover, local manufacturing and distribution partnerships are facilitating better access to respiratory monitoring devices. Companies like BPL Medical Technologies and Mindray have established regional supply chains to cater to the growing demand. With ongoing investments in healthcare digitization and increasing collaboration between public and private stakeholders, South Africa remains a key market for respiratory monitoring devices in the MEA region.

Egypt Respiratory Monitoring Devices Market Analysis

Egypt’s large population base, coupled with rising urbanization and air pollution levels, has resulted in a growing burden of respiratory ailments, thereby increasing demand for monitoring and diagnostic equipment.

One of the major growth drivers is the rising prevalence of chronic obstructive pulmonary disease (COPD). According to the Egyptian Ministry of Health, over 4 million adults suffer from COPD, largely due to high smoking rates and exposure to indoor air pollutants from cooking fuels. To address this, the government has expanded its national non-communicable disease (NCD) strategy to include enhanced pulmonary diagnostics in primary healthcare centers.

Additionally, Egypt has witnessed a surge in healthcare spending over the past few years. Furthermore, Egypt’s participation in the African Continental Free Trade Area (AfCFTA) has enabled greater import and export of medical devices, boosting availability and affordability. With rising public awareness and expanding healthcare access, Egypt is emerging as a key growth engine for the MEA respiratory monitoring market.

Israel Respiratory Monitoring Devices Market Analysis

Israel plays a crucial role in the MEA market due to its advanced healthcare infrastructure, innovation-driven medical technology sector, and strategic export relationships.

A key driver of growth is the country’s leadership in respiratory research and development. Israeli startups and academic institutions are at the forefront of developing cutting-edge monitoring solutions, including AI-powered sleep apnea detectors and miniaturized capnographs.

Additionally, the high prevalence of respiratory diseases in Israel, particularly among the aging population, is fueling demand for advanced monitoring tools. The country’s universal health coverage system also facilitates broader access to these technologies.

Moreover, Israel exports a significant portion of its respiratory monitoring devices to neighboring countries and African markets, leveraging its reputation for quality and reliability. With a strong R&D base, supportive regulatory environment, and growing regional trade linkages, Israel continues to be a vital contributor to the MEA respiratory monitoring devices market.

COMPETITIVE LANDSCAPE

The competition in the MEA respiratory monitoring devices market is characterized by a mix of global industry leaders and emerging regional players striving to capture market share through innovation, localization, and strategic partnerships. While multinational corporations dominate the高端 segment with advanced diagnostic and monitoring technologies, smaller firms and local manufacturers are gaining traction by offering cost-effective alternatives tailored to the region’s diverse healthcare needs. The market remains fragmented in certain segments, especially in lower-income countries where affordability and accessibility play a crucial role in purchasing decisions. Innovation is a key differentiator, with companies increasingly focusing on portable, wearable, and digitally integrated devices that cater to the growing demand for home-based respiratory care. Additionally, regulatory compliance and adaptability to varying country-specific requirements pose ongoing challenges for market participants. As healthcare infrastructure improves across the region, competition is expected to intensify, particularly in urban centers where demand for high-quality, technologically advanced respiratory monitoring solutions is rising. The ability to navigate complex regulatory landscapes, invest in after-sales service, and build sustainable partnerships with government and private healthcare entities will be critical for long-term success in this evolving market

KEY MARKET PLAYERS

A few of the noteworthy companies operating in the respiratory monitoring devices market include

• Covidien
• GE Healthcare
• Philips Healthcare
• Siemens Healthineers
• ResMed
• Merck & Co., Inc.
• Calando Pharmaceuticals Inc.
• Quark Pharmaceuticals Inc.
• Access Pharmaceuticals Inc.
• Sirnaomics Inc.
• Traversa Therapeutics Inc.

Top Players in the MEA Respiratory Monitoring Devices Market

Philips Healthcare

Philips is a global leader in healthcare technology and plays a dominant role in the MEA respiratory monitoring devices market. The company offers a comprehensive portfolio of respiratory monitoring solutions, including advanced pulse oximeters, sleep test devices, and capnographs. In the MEA region, Philips has been instrumental in integrating digital health platforms with respiratory diagnostics, supporting remote patient monitoring and telehealth initiatives. Its focus on innovation, strategic partnerships with regional healthcare providers, and strong distribution network have enabled it to maintain a competitive edge. Philips continues to drive adoption through tailored product development that addresses local healthcare challenges in the MEA market.

ResMed Inc.

ResMed specializes in sleep-disordered breathing and respiratory care devices, making it a key player in the MEA market. The company's presence in the region has grown significantly due to its focus on home-based respiratory monitoring solutions such as portable sleep apnea monitors and smart CPAP devices. In the MEA region, ResMed supports public health programs by providing accessible and user-friendly diagnostic tools for obstructive sleep apnea and COPD. Through collaborations with local governments and distributors, the company enhances awareness and access to respiratory care. Its commitment to improving patient outcomes through connected health technologies has strengthened its position in the MEA market.

GE Healthcare

GE Healthcare is a major contributor to the MEA respiratory monitoring devices market, offering a wide range of diagnostic and monitoring equipment used in hospitals and clinics across the region. The company’s expertise in medical imaging and patient monitoring systems extends to respiratory diagnostics, where it provides high-precision gas analyzers and integrated pulmonary function testing systems. In the MEA region, GE Healthcare supports large-scale hospital modernization projects and collaborates with public health institutions to improve access to critical care technologies. Its investments in training, service support, and digital integration further reinforce its leadership in the MEA respiratory monitoring market.

Top Strategies Used by Key Market Participants

One of the primary strategies employed by leading players in the MEA respiratory monitoring devices market is expanding their regional footprint through localized distribution networks. Companies are partnering with domestic distributors and healthcare providers to ensure better product availability and after-sales service, particularly in rural and underserved areas. This approach helps them overcome logistical barriers and enhance market penetration.

Another key strategy is leveraging digital health technologies to offer connected respiratory monitoring solutions. Major players are integrating cloud-based platforms, mobile applications, and AI-driven analytics into their devices to enable real-time patient monitoring and data sharing with healthcare professionals. This shift aligns with the growing emphasis on telemedicine and remote care delivery in the MEA region.

Lastly, companies are focusing on collaborating with public health authorities and investing in education and awareness programs. By conducting training sessions for healthcare workers and launching patient outreach campaigns, they aim to increase disease awareness and promote early diagnosis, which in turn drives demand for respiratory monitoring devices.

RECENT MARKET DEVELOPMENTS

• In January 2024, Philips launched a new line of portable pulse oximeters specifically designed for use in low-resource settings across Sub-Saharan Africa. This initiative aimed at expanding access to essential respiratory monitoring tools in rural clinics and community health centers.
• In March 2024, ResMed partnered with a leading Egyptian healthcare distributor to strengthen its supply chain and improve product availability in North Africa, ensuring faster delivery of sleep apnea and COPD monitoring devices in the region.
• In May 2024, GE Healthcare introduced an integrated pulmonary diagnostics platform in Saudi Arabia, combining spirometry, gas analysis, and digital reporting to support enhanced respiratory disease management in tertiary hospitals.
• In July 2024, Masimo expanded its presence in the UAE by opening a regional training center focused on educating clinicians on the use of advanced pulse oximetry and respiratory monitoring technologies in critical care settings.
• In September 2024, Nihon Kohden collaborated with South African health authorities to deploy portable spirometers in primary healthcare facilities as part of a national screening program targeting chronic respiratory diseases in high-risk populations.

MARKET SEGMENTATION

This research report on the MEA respiratory monitoring devices market has been segmented and sub-segmented into the following categories.

By Diagnostic Devices

• Spirometers
• Peak Flow Meter

By Monitoring Devices

• Sleep Test Devices
• Gas Analyzers
• Pulse Oximeters
• Capnograph

By Country

• KSA
• UAE
• Israel
• The Rest of the GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA